WuXi NextCODE Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:N/A
Industry:Biotech
Founded:2013
Lead Investor(s):N/A

Estimated Revenue & Financials

  • WuXi NextCODE's estimated annual revenue is currently $33.3M per year.
  • WuXi NextCODE received $200.0M in venture funding in November 2018.
  • WuXi NextCODE's estimated revenue per employee is $155,000

Employee Data

  • WuXi NextCODE has 215 Employees.
  • WuXi NextCODE grew their employee count by -23% last year.
  • WuXi NextCODE currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$8.7M56-12%N/A-N/A
#2
$8.7M5660%N/A-N/A
#3
$16.4M10614%N/A-N/A
#4
$89.4M577N/AN/A-N/A
#5
$116.9M754N/AN/A-N/A
#6
N/A220N/AN/A-N/A
#7
$15.3M99-17%N/A-N/A
#8
N/A94N/AN/A-N/A
#9
$54.6M352N/AN/A-N/A
#10
$17.2M1119%N/A-N/A
Missing a competitor? Contribute!?
Submit

WuXi NextCODE is a global biotechnology company harnessing genomic big data to propel drug discovery, clinical diagnoses, population health, and precision medicine. We are the pioneers of the biggest dataset in the world. We've crafted a common language to harmonize all types of genomic data and unlock insights at unprecedented speed and scale. Our comprehensive platform has been used by world-class hospitals to deliver over 12K diagnoses to rare disease patients. We serve twelve out of the world's top fifteen pharmaceutical companies. We are the platform of choice for the world's largest population projects. WuXi NextCODE offers genomic data solutions, from sample to answer. Partner with us from end-to-end, or choose from a suite of solutions spanning sequencing, storage, analysis, and reports. In addition to our industry solutions, we provide consumer products in China for wellness, reproductive health, and rare disease diagnostics.

keywords:N/A

215

Number of Employees

$33.3M

Revenue (est)

1

Current Jobs

-23%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

WuXi NextCODE News

09/06/2019 - Bioinformatics Market at a CAGR of 16.5% Growth, Trends ...

... of 16.5% Growth, Trends and Absolute Opportunity up to 2026 | Thermo Fisher Scientific, Illumina, Agilent Technologies, QIAGEN, BGI , Wuxi NextCODE.

09/04/2019 - China Genetic Testing Market Unexpected Growth Seen in ...

The China Genetic Testing Market is expected to reach a value of US$ 4.90 Billion by 2024, exhibiting a CAGR of +16% during 2019-2025.

08/17/2019 - Human rights group calls for genetic data firm probe

GMI, which was founded in 2015, was acquired last year by Chinese-owned WuXi NextCode. The firm aims to harvest genetic data from ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$45.2M215N/AN/A-N/A
#2
$22M216N/AN/A-N/A
#3
$22M216N/AN/A-N/A
#4
$22M216N/AN/A-N/A
#5
N/A216N/AN/A-N/A

WuXi NextCODE Funding

DateAmountRoundLead InvestorsReference
2013-10-24$15.0MAPolaris PartnersArticle
2017-05-02$75.0MBTemasekArticle
2017-09-08$240.0MBSequoia ChinaArticle
2018-11-28$200.0MCIreland Strategic Investment FundArticle

WuXi NextCODE Executive Hires

DateNameTitleReference
2014-12-02Thomas CaskeySVP Medical Science/DiagnosticsArticle
2017-03-01Hannes SmarasonCEOArticle
2017-09-14Rob Braininexecutive vice president and chief operating officerArticle
2017-11-10John GuChief Digital OfficerArticle
2018-03-13Rob BraininChief Executive OfficerArticle